CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病

科研文章

荐读文献

Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When MINOCA: a heterogenous group of conditions associated with myocardial damage 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes When, where, and how to target vascular inflammation in the post-CANTOS era? Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design
|<<... 8 9 10 11 12 13 14 >>|

Review ArticleApril 15, 2020

JOURNAL： Article Link

The Science Underlying COVID-19: Implications for the Cardiovascular System

PP Liu, A Blet, D Smyth et al. Keywords: COVID-19; pre-existing cardiovascular disease; ACE2 receptor; organ dysfunction;

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top